STAT+: HHS issues new initiatives to reduce animal testing in drug development
For the second time this year, HHS announced new strategies to speed the away from animals in medical testing.
The Department of Health and Human Services announced a new set of strategies on Tuesday to accelerate the transition towards human-based research methods and minimize the reliance on animals in medical testing, marking the second such initiative this year. The Food and Drug Administration (FDA) published a final rule permitting the utilization of alternative research methods, provided they are deemed "appropriate" for assessing drug and biologic safety.
This rule replaces phrases like "animal tests" and "animal studies" with "nonclinical tests" and "nonclinical studies." Concurrently, the National Institutes of Health (NIH) unveiled several initiatives, including $88 million in funding for 10 infrastructure projects distributed nationwide. These projects are specifically designed to promote the adoption of "new approach methodologies," such as cell-based assays, organs-on-a-chip, and computer models, among other innovative techniques.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
